Ratos : Ratos: Johan von Heijne new CEO of Biolin Scientific

         Ratos : Ratos: Johan von Heijne new CEO of Biolin Scientific

 This information is disclosed in accordance with the Securities Markets Act,
 the Financial Instruments Trading Act or demands made in the exchange rules.

Johan von Heijne has been appointed as the new CEO of Ratos's subsidiary
Biolin Scientific with effect from 1 February 2013. Johan von Heijne has long
and sound experience within the biotechnology sector.

Johan von Heijne, born 1961, will join Biolin Scientific from GE Healthcare
Life Sciences where he has been General Manager of the Research Products
business area since 2008. In this role Johan was responsible for a product
area with annual sales of USD 500m worldwide and manager for more than 100
employees in several countries. He has previously held leading positions
within Biacore and Radi Medical, among others.

The Chairman of Biolin's Board, Peter Ehrenheim, comments: "Johan von Heijne
has broad experience within Life Sciences Tools, and a documented ability to
get things done, most recently at General Electric. His broad experience and
strategic talents make him a highly suitable CEO for Biolin Scientific. We on
the Board are convinced that Johan, together with other members of the
management team, can develop Biolin Scientific into a strong and expansive
company."

Johan von Heijne will take up his position on 1 February 2013 and succeed Jan
Wahlström.

Biolin Scientific develops, manufactures and markets analytical instruments
for research, development, quality control and dental diagnostics. The company
is specialised in surface measurement with applications within Life Sciences
but also within material science and nanotechnology. The company also holds a
very strong position within cell analysis for pharmaceutical development.
Customers are found worldwide and mainly comprise researchers in
pharmaceutical companies and universities.

For further information, please contact:
Henrik Joelsson, Investment Director, Ratos, +46 8700 17 00
Peter Ehrenheim, Chairman of Biolin Scientific, +46 706 67 57 11
Johan von Heijne, incoming CEO Biolin Scientific, +46 705 95 15 10
Emma Rheborg, Head of Corporate Communications and IR, Ratos, +46 8700 17 00

Financial calendar from Ratos:

Year-end report 2012                           15 February 2013
Annual General Meeting 2013                    17 April 2013
Interim Report January - March 2013            8 May 2013
Interim Report January - June 2013             15 August 2013
Interim Report January - September 2013 8 November 2013

Ratos is a private equity conglomerate. The company's mission is to maximise
shareholder value over time through the professional, active and responsible
exercise of its ownership role in primarily medium to large unlisted Nordic
companies. Ratos's holdings include AH Industries, Arcus-Gruppen, Biolin
Scientific, Bisnode, DIAB, Euromaint, Finnkino, GS-Hydro, Hafa Bathroom Group,
HL Display, Inwido, Jøtul, KVD Kvarndammen, Mobile Climate Control, SBSeating
and Stofa. Ratos is listed on Nasdaq OMX Stockholm and market capitalisation
amounts to approximately SEK 20 billion.

Press release

------------------------------------------------------------------------------

This announcement is distributed by Thomson Reuters on behalf of Thomson
Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other
applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of
the
information contained therein.

Source: Ratos via Thomson Reuters ONE
HUG#1669668
 
Press spacebar to pause and continue. Press esc to stop.